TY - JOUR
T1 - Scientists' perspectives on consent in the context of biobanking research
AU - Master, Zubin
AU - Campo-Engelstein, Lisa
AU - Caulfield, Timothy
N1 - Funding Information:
We are most appreciative for the scientists who graciously volunteered their time to participate in the interview. We would also like to thank the Select Bioscience meeting organizers, in particular Ms Hannah Tweed, for permitting us to conduct interviews at the ELA 2013 conference. ZM was invited to the ELA 2013 conference to speak on ELS issues of biobanking and registration and accommodations were covered by conference organizers. We would like to thank the two anonymous reviewers for thoughtful comments and Mr Michael S. Opare-Addo for technical assistance on the project. Transcription of interviews was performed by Cabbage Tree Solutions. This work was in part supported by Professor Caulfield’s grants from the Cancer Stem Cell Consortium (CSCC) with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047); Allergy, Genes and Environment Network of Centres of Excellence Inc. (AllerGen); Paceomics (Genome Alberta); the Interdisciplinary Chronic Disease Collaboration funded by the Alberta Heritage Foundation for Medical Research (Alberta Innovates); and the cbcf Tumor Bank. We are most appreciative for project support by Ms Faria Grant, Ms Robyn Hyde-Lay and Ms Nicki Baron.
Publisher Copyright:
© 2015 Macmillan Publishers Limited All rights reserved.
PY - 2015/5/21
Y1 - 2015/5/21
N2 - Most bioethics studies have focused on capturing the views of patients and the general public on research ethics issues related to informed consent for biobanking and only a handful of studies have examined the perceptions of scientists. Capturing the opinions of scientists is important because they are intimately involved with biobanks as collectors and users of samples and health information. In this study, we performed interviews with scientists followed by qualitative analysis to capture the diversity of perspectives on informed consent. We found that the majority of scientists in our study reported their preference for a general consent approach although they do not believe there to be a consensus on consent type. Despite their overall desire for a general consent model, many reported several concerns including donors needing some form of assurance that nothing unethical will be done with their samples and information. Finally, scientists reported mixed opinions about incorporating exclusion clauses in informed consent as a means of limiting some types of contentious research as a mechanism to assure donors that their samples and information are being handled appropriately. This study is one of the first to capture the views of scientists on informed consent in biobanking. Future studies should attempt to generalize findings on the perspectives of different scientists on informed consent for biobanking.
AB - Most bioethics studies have focused on capturing the views of patients and the general public on research ethics issues related to informed consent for biobanking and only a handful of studies have examined the perceptions of scientists. Capturing the opinions of scientists is important because they are intimately involved with biobanks as collectors and users of samples and health information. In this study, we performed interviews with scientists followed by qualitative analysis to capture the diversity of perspectives on informed consent. We found that the majority of scientists in our study reported their preference for a general consent approach although they do not believe there to be a consensus on consent type. Despite their overall desire for a general consent model, many reported several concerns including donors needing some form of assurance that nothing unethical will be done with their samples and information. Finally, scientists reported mixed opinions about incorporating exclusion clauses in informed consent as a means of limiting some types of contentious research as a mechanism to assure donors that their samples and information are being handled appropriately. This study is one of the first to capture the views of scientists on informed consent in biobanking. Future studies should attempt to generalize findings on the perspectives of different scientists on informed consent for biobanking.
UR - http://www.scopus.com/inward/record.url?scp=84928059946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928059946&partnerID=8YFLogxK
U2 - 10.1038/ejhg.2014.143
DO - 10.1038/ejhg.2014.143
M3 - Article
C2 - 25074466
AN - SCOPUS:84928059946
SN - 1018-4813
VL - 23
SP - 569
EP - 574
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 5
ER -